CEO
Alivus Life Sciences Limited
Equibles does not estimate personal net worth.
Yasir Raoji is recorded as CEO at Alivus Life Sciences Limited. Yasir Raoji has spoken on 3 earnings calls across 1 company, most recently for Alivus Life Sciences Limited on October 30, 2026. Alivus Life Sciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Let me begin by extending our warm wishes for the upcoming activities. Turning to our performance, we are pleased to report another quarter of healthy execution reflecting the strength of our underlying business and a significant improvement in profitability.”
“We are pleased to begin the first quarter on a positive note, marked by healthy revenue growth, improving profitability, and continuing momentum across our markets.”
“I am pleased to share that this year marks an important milestone in the journey of Alivist Life Sciences as we complete two full years with NIRMA as our promoter.”
Alivus Life Sciences Limited
CEO
Transcript header (unverified)
Alivus Life Sciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Earnings Call
Alivus Life Sciences Limited
Earnings Call for the Quarter Ended June 30, 2026
Alivus Life Sciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Alivus Life Sciences Limited
